Low-dose co-trimoxazole for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus disease

Authors:

MLMarc LaRiviere
Marc LaRiviere

Publisher website

1 February 1991

journal article
Published by Elsevier in The Lancet

Vol. 337 (8739) , 468-471
DOI:10.1016/0140-6736(91)93402-u
PMID:1671479

Abstract

No abstract available

Keywords

This publication has 13 references indexed in Scilit:

A Randomized Controlled Trial of a Reduced Daily Dose of Zidovudine in Patients with the Acquired Immunodeficiency Syndrome
New England Journal of Medicine, 1990
Aerosolized Pentamidine for Prophylaxis againstPneumocystis cariniiPneumonia
New England Journal of Medicine, 1990
Extrapulmonary Pneumocystis carinii Infections
Clinical Infectious Diseases, 1990
The Risk ofPneumocystis cariniiPneumonia among Men Infected with Human Immunodeficiency Virus Type 1
New England Journal of Medicine, 1990
PREVENTION OF PNEUMOCYSTIS CARINII PNEUMONIA RELAPSE BY PENTAMIDINE AEROSOL IN ZIDOVUDINE-TREATED AIDS PATIENTS
The Lancet, 1989
PREVENTION OF PNEUMOCYSTIS CARINII PNEUMONIA BY INHALED PENTAMIDINE
The Lancet, 1989
Trimethoprim-Sulfamethoxazole Compared with Pentamidine for Treatment of Pneumocystis carinii Pneumonia in the Acquired Immunodeficiency Syndrome
Annals of Internal Medicine, 1988
Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS
JAMA, 1988
Successful Intermittent Chemoprophylaxis forPneumocystis cariniiPneumonitis
New England Journal of Medicine, 1987
Successful Chemoprophylaxis forPneumocystis cariniiPneumonitis
New England Journal of Medicine, 1977